Magazine issue

July/August 2021

July/August 2021

Whilst we have seen the COVID pandemic wreak havoc on care pathways across the country, it has also spurred closer and...

June 2021

June 2021

This month’s PharmaTimes is packed with a variety of features centred on clinical research, the lifeblood of our...

May 2021

May 2021

This month we celebrate women from various factions of healthcare who are all striving to achieve better outcomes for...

April 2021

April 2021

With the anchor now securely lodged in 2021, what’s on the horizon for the life sciences industry and for healthcare...

March 2021

March 2021

This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again...

January/February 2021

January/February 2021

Despite entering another national lockdown, we begin this year with a great deal more hope for a return to ‘normality’...

December 2020

December 2020

2020 will undoubtedly go down in history as being the year the world as we know it was crushed by a new coronavirus,...

November 2020

November 2020

Our cover feature this month (p19) highlights pharma’s laudable ability to continually innovate in the logistics...

October 2020

October 2020

In this month’s issue of PharmaTimes we take a closer look at plans for the NHS Reset, which essentially aims to embed...

September 2020

September 2020

Welcome to the patient-centricity special! Articles in this issue shine a light on how pharma is making strides in...

July/August 2020

The future is diversity. That is the central, take-home message of our cover feature this month on diversity and...

June 2020

As part of our theme of celebrating positives in pharma and health during this difficult and turbulent time, while...

May 2020

COVID-19 will rightfully continue to dominate the news and our thoughts over the course of the pandemic and beyond,...

April 2020

As the impact of the global COVID-19 pandemic hits hard and fast, PharmaTimes is open for business as usual and our...

March 2020

It’s really heartening to see that the UK’s smaller, privately owned pharma sector continues to thrive in an operating...